THE PECULIARITIES OF THE CHANGE OF THE ENDOTHELIAL FUNCTION IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS OF ITS COMORBIDITY WITH ESSENTIAL HYPERTENSION


  • Ye.Ye. Petrov Ukrainian Medical Stomatological Academy, The 4th city clinical hospital Poltava, Ukraine
  • Yu.G. Burmak Ukrainian Medical Stomatological Academy, The 4th city clinical hospital Poltava, Ukraine
  • I.Yu. Gordiychuk Ukrainian Medical Stomatological Academy, The 4th city clinical hospital Poltava, Ukraine
  • S.I. Treumova Ukrainian Medical Stomatological Academy, The 4th city clinical hospital Poltava, Ukraine
Keywords: chronic obstructive pulmonary disease, comorbidity, endothelial dysfunction.

Abstract

THE PECULIARITIES OF THE CHANGE OF THE ENDOTHELIAL FUNCTION IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS OF ITS COMORBIDITY WITH ESSENTIAL HYPERTENSION

References

1. Chandy D, Aronov WS, Banach M. Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease. Integrated Blood Pressure Control. 2013; 6: 101-109.

2. Hadley EC, Lakatta EG, Morrison-Bogorad et al. The future of aging therapies. Cell. 2005; vol. 120, 4: 557-667.

3. Karoli NA, Rebrov AP. [Vascular Walls as Target Organ in Comorbid Patients][Published in Russian]. Rational Pharmacotherapy in Cardiology. 2017; 13(4): 513-518.

4. Kirkwood TB. Understanding the old science of aging. Cell. 2005; vol.120, 4: 437-447.

5. Kraemer HC. Statistical issues in assessing comorbidity. Statistics in Medicine; 1995; vol.14: 721-723.

6. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. American Journal of Public Health. 1992; vol.82, 5: 703-710.

7. Makarova MA, Avdeev SN, Chuchalin AG. [Arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease: what is primary and secondary?] [Published in Russian]. Russian Pulmonology. 2011; 6: 73-79.

8. Mordi I, Mordi N, Delles Ch, Tremos N. Endothelial dysfunction in human essential hypertension. Journal of Hypertension. 2016; 34(8): 1464-1472.

9. Pavlov P, Ivanov Y, Glogovska P et al. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease. European Respiratory Journal. 2012; vol. 40, suppl. 56: 174.

10. Polverino F, Celli BR, Owen CA. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? Pulmonary Circulation. 2018; 8(1): 1-18.

11. Sadykova DI, Sergeyeva EV, Aflyatumova GN. [Role of endothelial dysfunction in hypertension in children and adolescents ][Published in Russian]. Practical Medicine. 2014; 9(85): 24-27.

12. Van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity: what’s is a name? A review of literature. European Journal of General Practice. 1996; vol. 2, 2: 65-70.

13. Vyortkin AL, Khovasova NO. [Comorbidity – new pathology. Technologies of its prophylaxis and treatment][Published in Russian]. The Russian Archives of Internal Medicine. 2013; 4: 68-72.
Published
2019-11-07
How to Cite
Petrov, Y., Burmak, Y., Gordiychuk, I., & Treumova, S. (2019). THE PECULIARITIES OF THE CHANGE OF THE ENDOTHELIAL FUNCTION IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS OF ITS COMORBIDITY WITH ESSENTIAL HYPERTENSION. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 86-87. https://doi.org/10.29256/v.03.01.2019.escbm57
Section
Selected abstracts